Kiniksa Pharmaceuticals · 14 hours ago
Vice President, Research & Non-Clinical Development
Kiniksa Pharmaceuticals is seeking a Vice President of Research & Non-clinical Development to join their innovative team and accelerate drug candidates to approval. The role involves driving pre-clinical and translational activities for the company's pipeline of biologics programs within autoimmune and cardiovascular therapeutic areas, providing strategic and scientific leadership, and managing a high-performance team.
BiopharmaBiotechnologyMedical
Responsibilities
Work closely with leaders across the company to plan and execute on the R&D strategy
Lead, manage, develop, and retain a high-performance team, and provide development opportunities and mentoring to the team
Provide strategic and scientific leadership to develop integrated research plans
Lead translational research across research and development groups, collaborating with medical directors, clinical pharmacologists and nonclinical research scientists; ensure early definition of clinical development strategy and biomarker plans
Guide execution of drug discovery research and preclinical (IND-enabling) activities to enable robust, timely and compliant IND submissions with clear development paths
Oversee DMPK/ADME and toxicology studies supporting the advancement of pre-FIH development programs into clinical stage as well as other non-clinical activities in support of ongoing clinical development programs
Plan, resource and prioritize in-house and outsourced pharmacology activities
Provide support and guidance for in vivo work with several exciting external academic/industry collaborators and with CROs
Evaluate new therapeutic opportunities, and initiate additional pipeline programs in close collaboration with business development and medical affairs
Manage a portfolio of therapeutics across diverse disease areas
Communicate scientific data internally and externally by overseeing messaging for study reports and regulatory documentation, contributing to high impact scientific manuscripts, identifying & managing external research collaborations, and engaging with scientific advisors and consultants
Foster a culture of collaboration, innovation, discovery, and cutting-edge research focused on scientific excellence, open communication, and continual improvement
Qualification
Required
Requires a PhD with 15+ years of industry experience in translation research and drug discovery
Demonstrated ability to transition program from preclinical stage through IND into early clinical development
Deep understanding of in vivo pharmacology and strong track record of driving research stage programs into the clinic
Track record of excellence and innovation as demonstrated by multiple peer reviewed publications and co-inventorship on patents
Ability to work productively with and influence diverse project leads on cross functional project teams
Engaging personality and strong leadership, mentoring and people management skills
Ability to think strategically and execute tactically
Excellent verbal and written communication skills, strong presentation skills, and demonstrated ability to manage by influence and problem solve in a highly matrixed organization
Prior success with research in a hands-on, highly collaborative growth environment, the ability to work effectively both independently and as part of multi-disciplinary team in a fast-paced environment
Experience working in cultures where courage, commitment and excellence are the backbone of the leadership profile
Preferred
specific experience with biologics
Company
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
H1B Sponsorship
Kiniksa Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (3)
2022 (4)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$400MKey Investors
Baker Brothers Advisors LLC
2020-05-13Post Ipo Equity· $80M
2018-05-23IPO
2018-02-01Series C· $200M
Leadership Team
Recent News
2025-12-09
2025-10-29
2025-10-29
Company data provided by crunchbase